Rajbir Singh

Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease.

V. Jala, A. Pandit, P. Vemula, 2022, Biomaterials.

The influence of single-nucleotide polymorphisms on overall survival and toxicity in cabazitaxel-treated patients with metastatic castration-resistant prostate cancer

R. Mathijssen, R. V. van Schaik, R. de Wit, 2020, Cancer Chemotherapy and Pharmacology.

Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway

E. Rouchka, H. Alatassi, V. Jala, 2019, Nature Communications.

Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis

V. Jala, B. Haribabu, P. Vemula, 2022, Theranostics.

Effects of pharmacogenetic variants on vemurafenib-related toxicities in patients with melanoma.

R. Mathijssen, R. V. van Schaik, A. Goey, 2019, Pharmacogenomics.